Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza Pockets $1M from NIH to Re-engineer Phrap

NEW YORK, March 19 - Geospiza on Tuesday said that the US National Institutes of Health has awarded it $1.1 million to "re-engineer" its Phrap gene-sequencing technology.


Geospiza and its research partner Southwest Parallel Software will use the cash to "improve Phrap's ability to use external information" to help researchers assemble gene sequences. These modifications will make the technology "better suited for high-throughput data processing," Geospiza said.


Phrap-based research has over the past few years expanded to include SNP and mutation discovery, expression analysis, bacterial sequencing, and confirmatory sequencing, the company said in a statement.


"Phrap was originally developed with a more narrow focus as a tool to assist genome centers sequencing cosmids," Todd Smith, president of Geospiza, said in the statement. "But people are using Phrap for new things now and the applications for [it] have increased...."

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.